Improving an Imperfect View

The role of adaptive optics in monitoring retinal disease.

Read Article


Visit @RetinaToday on Twitter

Articles From This Issue


Image All the People


Medical Editors’ Page

Imagine there’s no blindness. It’s easy if you try. No diseased retinas, only healthy eyes. Imagine all the people … seeing every day. You may say we&rs…

Retina News

BROLUCIZUMAB NONINFERIOR TO AFLIBERCEPT IN PHASE 3 STUDIES IN AMD Brolucizumab (RTH258, Novartis) demonstrated noninferiority to aflibercept (Eylea, Regeneron) in the prima…

  • Diabetes Awareness Month
  • OCT-A Disease Education Resource Center
  • AMD Awareness Month
  • DME Disease Education Resource Center
  • Uveitis Resource Center
  • AMD Disease Education Resource Center
  • NEWS


    Regeneron Announces FDA Acceptance of sBLA Filing for 12-Week Dosing of Eylea (aflibercept) for Patients with Wet AMD

    Regeneron announced that the FDA has accepted for review the company's supplemental Biologics Li…

    Second Sight Announces Market Entry into Iran with First Two Implants of Argus II Retinal Prosthesis System

    Second Sight Medical Products announced market entry into Iran, implanting the first two patients wi…

    Contact Info

    Bryn Mawr Communications LLC
    1008 Upper Gulph Road, Suite 200
    Wayne, PA 19087

    Phone: 484-581-1800
    Fax: 484-581-1818

    Karen Roman

    Janet Burk

    About Retina Today

    Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.